UNC Project-Malawi, Private Bag A-104, Lilongwe, Malawi.
U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
BMC Womens Health. 2021 Mar 20;21(1):114. doi: 10.1186/s12905-021-01236-1.
Although many countries have been promoting hormonal contraceptives to prevent unintended pregnancy and condom use to prevent HIV transmission, little is known about how women targeted by these messages have interpreted and internalized them. We describe HIV-positive and negative women's understanding of the benefits of contraception and condoms and their motivations to use them.
This is a qualitative sub-study from a clinical trial evaluating the effects of progestin contraception on HIV-positive and negative women aged 18-45 years randomly assigned to depot medroxyprogesterone acetate (DMPA) injection or levonorgestrel (LNG) implant. We purposively recruited 41 women to participate in in-depth interviews (IDIs) and focus group discussions (FGDs) after randomization into the main study. We conducted a total of 30 IDIs and 6 FGDs comprised of 4-7 women (N = 32). All women were counselled about potential risks for HIV acquisition/transmission with progestin-only contraception, drug-drug interactions between the implant and efavirenz-based ART, and the need to use condoms with their assigned contraceptive to help prevent pregnancy and HIV acquisition and transmission.
All women understood that HIV is transmitted through unprotected sex and that HIV transmission can be prevented through condom use but not DMPA injection or LNG implant use. Nearly all HIV-positive women knew or suspected that their partners were also HIV-positive and were most interested in using condoms to prevent infection with a drug-resistant HIV strain to keep their HIV viral load low. Almost all reported that their partners agreed to condom use, but few used them consistently. Most women believed that condoms were effective at preventing both HIV and pregnancy if used consistently. Nearly all women considered contraception and condom use as important in preventing unintended pregnancy and HIV because partner disclosure of HIV status is low.
Our results showed that both HIV-positive and negative women understood modes of HIV transmission and prevention and were aware that hormonal contraceptives are only effective for preventing pregnancy and not HIV. Although both HIV-negative and positive women were motivated to use condoms to prevent both HIV acquisition and infection with other HIV strains respectively, they all faced challenges from their partners in using condoms consistently.
尽管许多国家一直在推广激素避孕措施以防止非意愿妊娠,推广避孕套以预防艾滋病毒传播,但对于这些信息的目标受众如何理解和内化这些信息,人们知之甚少。我们描述了艾滋病毒阳性和阴性妇女对避孕和避孕套益处的理解,以及她们使用这些措施的动机。
这是一项评估孕激素避孕对 18-45 岁艾滋病毒阳性和阴性妇女影响的临床试验的定性子研究,这些妇女被随机分配到 depot 甲羟孕酮醋酸酯(DMPA)注射或左炔诺孕酮(LNG)植入物。在随机进入主要研究后,我们有目的地招募了 41 名妇女参加深入访谈(IDIs)和焦点小组讨论(FGDs)。我们总共进行了 30 次 IDI 和 6 次 FGD,由 4-7 名妇女组成(N=32)。所有妇女都接受了关于孕激素避孕药具使用可能增加艾滋病毒感染/传播风险的咨询,包括植入物与依非韦伦为基础的抗逆转录病毒治疗之间的药物相互作用,以及需要与分配的避孕药具一起使用避孕套以帮助预防怀孕和艾滋病毒感染和传播。
所有妇女都明白艾滋病毒是通过无保护的性行为传播的,使用避孕套可以预防艾滋病毒传播,但 DMPA 注射或 LNG 植入物不能预防艾滋病毒传播。几乎所有艾滋病毒阳性妇女都知道或怀疑其伴侣也感染了艾滋病毒,她们最感兴趣的是使用避孕套来预防感染耐药性艾滋病毒株,以保持其艾滋病毒病毒载量低。几乎所有妇女都报告说,她们的伴侣同意使用避孕套,但很少有人一直使用。大多数妇女认为,如果一直使用避孕套,避孕套可以有效预防艾滋病毒和怀孕。几乎所有妇女都认为避孕和使用避孕套在预防意外怀孕和艾滋病毒方面很重要,因为伴侣告知艾滋病毒状况的情况很低。
我们的研究结果表明,艾滋病毒阳性和阴性妇女都了解艾滋病毒传播和预防模式,并且都知道激素避孕药具仅能预防怀孕,不能预防艾滋病毒。尽管艾滋病毒阴性和阳性妇女都有动机使用避孕套来分别预防艾滋病毒的获得和感染其他艾滋病毒株,但她们都面临着来自伴侣的使用避孕套的挑战。